ReviewBMJ open2021
Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review.
Piotr Ozieranski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it